8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors

Structure-activity relationships, X-ray crystallography and oral in vivo anti-tumor activity for a series of 8-THP-DHI dual TIE-2/VEGF-R2 inhibitors are reported.